4/4
02:11 am
rdy
Trump's latest tariff threat ends brief reprieve for Indian pharma stocks [Yahoo! Finance Canada]
Medium
Report
Trump's latest tariff threat ends brief reprieve for Indian pharma stocks [Yahoo! Finance Canada]
3/27
11:47 am
rdy
Bio-Thera and Dr. Reddy's Execute Exclusive Commercialization Agreement for BAT2206, a Proposed Stelara® Biosimilar, and BAT2506, a Proposed Simponi® Biosimilar, for Southeast Asia
Low
Report
Bio-Thera and Dr. Reddy's Execute Exclusive Commercialization Agreement for BAT2206, a Proposed Stelara® Biosimilar, and BAT2506, a Proposed Simponi® Biosimilar, for Southeast Asia
3/24
11:07 am
rdy
Henlius 2024 Annual Results: Steady Revenue Growth with a Net Profit of RMB820.5 million, Up by 50.3% YoY [Yahoo! Finance]
Low
Report
Henlius 2024 Annual Results: Steady Revenue Growth with a Net Profit of RMB820.5 million, Up by 50.3% YoY [Yahoo! Finance]
3/18
10:09 am
rdy
Alvotech and Dr. Reddy's gets FDA nod for Biologic License Application for AVT03 [Seeking Alpha]
Low
Report
Alvotech and Dr. Reddy's gets FDA nod for Biologic License Application for AVT03 [Seeking Alpha]
3/18
08:35 am
rdy
Alvotech and Dr. Reddy’s Announce FDA Acceptance of Biologic License Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®
Low
Report
Alvotech and Dr. Reddy’s Announce FDA Acceptance of Biologic License Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®
3/13
10:40 am
rdy
Dr. Reddy's Issues a Nationwide Recall of Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL, in the U.S., due to Mislabeling of Infusion Bag
Neutral
Report
Dr. Reddy's Issues a Nationwide Recall of Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL, in the U.S., due to Mislabeling of Infusion Bag
3/7
08:29 am
rdy
Will Trump Drug Tariffs Help Or Hurt The U.S.? [Forbes]
Low
Report
Will Trump Drug Tariffs Help Or Hurt The U.S.? [Forbes]
3/4
07:41 am
rdy
Pediatrica Health Group Acquires the Rainbow Pediatric Center Group of Practices and Sets a Course for Change [Yahoo! Finance]
Low
Report
Pediatrica Health Group Acquires the Rainbow Pediatric Center Group of Practices and Sets a Course for Change [Yahoo! Finance]
3/1
07:07 pm
rdy
Is Dr. Reddy's Laboratories Limited (RDY) the Best Weight Loss Drug Stock to Buy According to Analysts? [Yahoo! Finance]
Low
Report
Is Dr. Reddy's Laboratories Limited (RDY) the Best Weight Loss Drug Stock to Buy According to Analysts? [Yahoo! Finance]
2/11
08:41 am
rdy
Biosimilars Market Size to Hit USD 127.92 Billion by 2032, Growing at a 17.7% CAGR - SNS Insider [Yahoo! Finance]
Low
Report
Biosimilars Market Size to Hit USD 127.92 Billion by 2032, Growing at a 17.7% CAGR - SNS Insider [Yahoo! Finance]
2/10
08:23 am
rdy
Cosette Pharmaceuticals Appoints Vincent Colicchio as Senior Vice President of Operations [Yahoo! Finance]
Low
Report
Cosette Pharmaceuticals Appoints Vincent Colicchio as Senior Vice President of Operations [Yahoo! Finance]
2/7
08:32 am
rdy
Opportunities in the Omeprazole Market, 2025-2030: Dr. Reddy's Laboratories, Sandoz, and Perrigo Company Lead the Competition [Yahoo! Finance]
Low
Report
Opportunities in the Omeprazole Market, 2025-2030: Dr. Reddy's Laboratories, Sandoz, and Perrigo Company Lead the Competition [Yahoo! Finance]
2/6
08:13 am
rdy
Dr. Reddy's enters into collaboration with Henlius for commercialization of HLX15 (daratumumab), a biosimilar candidate to Darzalex® & Darzalex Faspro® in the U.S., and Europe [Yahoo! Finance]
Low
Report
Dr. Reddy's enters into collaboration with Henlius for commercialization of HLX15 (daratumumab), a biosimilar candidate to Darzalex® & Darzalex Faspro® in the U.S., and Europe [Yahoo! Finance]
2/6
07:51 am
rdy
Dr. Reddy’s enters into collaboration with Henlius for commercialization of HLX15 (daratumumab), a biosimilar candidate to Darzalex® & Darzalex Faspro® in the U.S., and Europe
Low
Report
Dr. Reddy’s enters into collaboration with Henlius for commercialization of HLX15 (daratumumab), a biosimilar candidate to Darzalex® & Darzalex Faspro® in the U.S., and Europe
2/6
06:43 am
rdy
Henlius and Dr. Reddy's Ink Licensing Deal for HLX15 (investigational daratumumab biosimilar) Expansion in Europe and the U.S.
Low
Report
Henlius and Dr. Reddy's Ink Licensing Deal for HLX15 (investigational daratumumab biosimilar) Expansion in Europe and the U.S.
2/6
06:40 am
rdy
Henlius and Dr. Reddy's Ink Licensing Deal for HLX15 (investigational daratumumab biosimilar) Expansion in Europe and the U.S.
Low
Report
Henlius and Dr. Reddy's Ink Licensing Deal for HLX15 (investigational daratumumab biosimilar) Expansion in Europe and the U.S.
2/6
06:35 am
rdy
Henlius and Dr. Reddy's Ink Licensing Deal for HLX15 (investigational daratumumab biosimilar) Expansion in Europe and the U.S.
Low
Report
Henlius and Dr. Reddy's Ink Licensing Deal for HLX15 (investigational daratumumab biosimilar) Expansion in Europe and the U.S.
2/5
02:53 am
rdy
Proton Pump Inhibitors (PPIs) Market to Grow by USD 819.5 Million (2025-2029) with Drug Reformulation Boosting the Market, Report on How AI is Redefining Market Landscape - Technavio [Yahoo! Finance]
Low
Report
Proton Pump Inhibitors (PPIs) Market to Grow by USD 819.5 Million (2025-2029) with Drug Reformulation Boosting the Market, Report on How AI is Redefining Market Landscape - Technavio [Yahoo! Finance]
1/24
08:41 am
rdy
Dr. Reddy's Laboratories Limited 2025 Q3 - Results - Earnings Call Presentation [Seeking Alpha]
Low
Report
Dr. Reddy's Laboratories Limited 2025 Q3 - Results - Earnings Call Presentation [Seeking Alpha]
1/24
02:32 am
rdy
Dr Reddy's Laboratories Ltd (RDY) Q3 2025 Earnings Call Highlights: Record Revenue Growth ... [Yahoo! Finance]
Low
Report
Dr Reddy's Laboratories Ltd (RDY) Q3 2025 Earnings Call Highlights: Record Revenue Growth ... [Yahoo! Finance]
1/24
01:37 am
rdy
Indian drugmaker Dr Reddy's shares slide after Q3 profit miss [Yahoo! Finance]
Low
Report
Indian drugmaker Dr Reddy's shares slide after Q3 profit miss [Yahoo! Finance]
1/23
12:35 pm
rdy
Dr. Reddy’s Q3 & 9MFY25 Financial Results
Low
Report
Dr. Reddy’s Q3 & 9MFY25 Financial Results
1/23
10:16 am
rdy
Indian drugmaker Dr Reddy's says it is 'optimistic' about Trump administration [Yahoo! Finance]
Low
Report
Indian drugmaker Dr Reddy's says it is 'optimistic' about Trump administration [Yahoo! Finance]